NGNE

Neurogene Inc.

Neurogene Inc. (NGNE) has 3 SEC Form 4 filings (7 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 8, 2026.

The most active filer is President and CFO Cvijic Christine Mikail with 5 filings. Insiders have net sold $640K over the trailing 6 months.

  • Industry:Biotechnology
  • CEO:Rachel L. McMinn
  • Employees:107
  • HQ:New York City, NY, US
  • IPO:2014-03-07

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$640K

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Market Cap

$617.5M

latest known value

Source
Sale$22KJul 8SEC ↗
Sale$152KJul 8SEC ↗
Sale$25KJul 2SEC ↗
Sale$141KJul 2SEC ↗
Sale$300KMay 8SEC ↗

Related companies

Neurogene Inc. is in the Healthcare sector.